Install
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES V
- 1,266articles · 90d
- 1+ day agolatest article
- Jun 15, 2026earliest in window
- 90%with images
- 304avg words
- Economy, Business & Finance 739
- Medical 567
- Health & Wellness 553
- Finance & Business 526
- Business & Industrial 468
- Health 300
- News 203
- Science & Technology 173
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Mighty Therapeutics Announces First Patient Dosed in Phase 4 Confirmatory Study of Elamipretide in Barth Syndrome
2+ mon, 4+ day ago (140+ words) – Comprehensive updates to be presented at Barth Syndrome Foundation conference – Mighty's presentations at the Barth Syndrome Foundation Conference are as follows: In September 2025, Mighty marked a historic milestone with the U.S. Food and Drug Administration (FDA) approval of its…...